Wang Zheng, Zhao Xiaopeng, Lu Mingjing, Wang Naiyu, Xu Shu, Min Dongyu, Wang Lijie
School of Medicine, Qilu Institute of Technology, Jinan, 250200, China.
College of Exercise and Health, Shenyang Sport University, Shenyang, 110102, China.
Mol Cell Biochem. 2025 Jun;480(6):3501-3520. doi: 10.1007/s11010-024-05204-9. Epub 2025 Feb 7.
Myocardial ischemia/reperfusion (I/R) injury has high morbidity and mortality rates, posing a significant burden on society. There is an urgent need to understand its pathogenesis and develop effective treatments. Reactive oxygen species (ROS) are crucial for the development of myocardial I/R injury, and inhibiting ROS overproduction is one of the most critical ways to delay myocardial I/R injury. Sirtuins are a group of nicotinic adenine dinucleotide ( +)-dependent histone deacetylases whose members can regulate ROS by modulating various biological processes. Numerous studies have shown that Sirtuins play an essential role in the progression of myocardial I/R injury by regulating ROS. This study focuses on the relationship between myocardial I/R injury and ROS, Sirtuins and ROS, discusses the role of Sirtuins in regulating ROS in myocardial I/R, and summarizes the therapeutic modalities aimed at targeting Sirtuins to modulate ROS in myocardial I/R injury, thereby guiding future research endeavors.
心肌缺血/再灌注(I/R)损伤具有较高的发病率和死亡率,给社会带来了沉重负担。迫切需要了解其发病机制并开发有效的治疗方法。活性氧(ROS)对于心肌I/R损伤的发展至关重要,抑制ROS的过度产生是延缓心肌I/R损伤的最关键方法之一。沉默调节蛋白是一组依赖烟酰胺腺嘌呤二核苷酸(+)的组蛋白脱乙酰酶,其成员可通过调节各种生物学过程来调控ROS。大量研究表明,沉默调节蛋白通过调控ROS在心肌I/R损伤的进展中发挥重要作用。本研究聚焦于心肌I/R损伤与ROS、沉默调节蛋白与ROS之间的关系,探讨沉默调节蛋白在心肌I/R中调控ROS的作用,并总结旨在靶向沉默调节蛋白以调节心肌I/R损伤中ROS的治疗方式,从而为未来的研究工作提供指导。